CA Patent

CA2235621A1 — Imidazole derivatives and their use as nitrogen monoxide synthase inhibitors

Assigned to Bayer Pharma AG · Expires 1997-05-01 · 29y expired

What this patent protects

The invention relates to the compounds of the formula (I), and to the preparation and use thereof in drugs.

USPTO Abstract

The invention relates to the compounds of the formula (I), and to the preparation and use thereof in drugs.

Drugs covered by this patent

Patent Metadata

Patent number
CA2235621A1
Jurisdiction
CA
Classification
—
Expires
1997-05-01
Drug substance claim
No
Drug product claim
No
Assignee
Bayer Pharma AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.